Gary I. Cohen

Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced <i>BRAF</i>-Mutant Melanoma: The DREAMseq Trial—ECOG-ACRIN EA6134

Michael B. Atkins, Sandra J. Lee, Bartosz Chmielowski et al. · Journal of Clinical Oncology · 2022 · 439 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Phase I Trial of Intravenous Administration of PV701, an Oncolytic Virus, in Patients With Advanced Solid Cancers

Andrew L. Pecora, Naiyer A. Rizvi, Gary I. Cohen et al. · Journal of Clinical Oncology · 2002 · 389 citations

Pharmacy, Oncology, Pharmacology +9

Exercise manages fatigue during breast cancer treatment: A randomized controlled trial

Victoria Mock, Constantine Frangakis, Nancy E. Davidson et al. · Psycho-Oncology · 2004 · 385 citations

Medicine, Oncology, Rehabilitation Medicine +17

Phase III Trial Comparing Concurrent Biochemotherapy With Cisplatin, Vinblastine, Dacarbazine, Interleukin-2, and Interferon Alfa-2b With Cisplatin, Vinblastine, and Dacarbazine Alone in Patients With Metastatic Malignant Melanoma (E3695): A Trial Coordinated by the Eastern Cooperative Oncology Group

Michael B. Atkins, Jessie J. Hsu, Gary I. Cohen et al. · Journal of Clinical Oncology · 2008 · 322 citations · Full text

Medicine, Oncology, Pharmacology +16

Comparable efficacy and safety profiles of once-per-cycle pegfilgrastim and daily injection filgrastim inchemotherapy-induced neutropenia: a multicenterdose-finding study in women with breast cancer

Frankie A. Holmes, Stephen E. Jones, Joyce O’Shaughnessy et al. · Annals of Oncology · 2002 · 292 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +11